199 related articles for article (PubMed ID: 21964595)
21. STAT5 is activated in macrophages by breast cancer cell-derived factors and regulates macrophage function in the tumor microenvironment.
Jesser EA; Brady NJ; Huggins DN; Witschen PM; O'Connor CH; Schwertfeger KL
Breast Cancer Res; 2021 Nov; 23(1):104. PubMed ID: 34743736
[TBL] [Abstract][Full Text] [Related]
22. Protein kinase Czeta phosphorylates nuclear factor of activated T cells and regulates its transactivating activity.
San-Antonio B; Iñiguez MA; Fresno M
J Biol Chem; 2002 Jul; 277(30):27073-80. PubMed ID: 12021260
[TBL] [Abstract][Full Text] [Related]
23. Cross-talk between signal transducer and activator of transcription (Stat5) and thyroid hormone receptor-beta 1 (TRbeta1) signaling pathways.
Favre-Young H; Dif F; Roussille F; Demeneix BA; Kelly PA; Edery M; de Luze A
Mol Endocrinol; 2000 Sep; 14(9):1411-24. PubMed ID: 10976919
[TBL] [Abstract][Full Text] [Related]
24. Orphan nuclear receptor small heterodimer partner negatively regulates growth hormone-mediated induction of hepatic gluconeogenesis through inhibition of signal transducer and activator of transcription 5 (STAT5) transactivation.
Kim YD; Li T; Ahn SW; Kim DK; Lee JM; Hwang SL; Kim YH; Lee CH; Lee IK; Chiang JY; Choi HS
J Biol Chem; 2012 Oct; 287(44):37098-108. PubMed ID: 22977252
[TBL] [Abstract][Full Text] [Related]
25. Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells.
Fox EM; Bernaciak TM; Wen J; Weaver AM; Shupnik MA; Silva CM
Mol Endocrinol; 2008 Aug; 22(8):1781-96. PubMed ID: 18550772
[TBL] [Abstract][Full Text] [Related]
26. PTP1B suppresses prolactin activation of Stat5 in breast cancer cells.
Johnson KJ; Peck AR; Liu C; Tran TH; Utama FE; Sjolund AB; Schaber JD; Witkiewicz AK; Rui H
Am J Pathol; 2010 Dec; 177(6):2971-83. PubMed ID: 20952588
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-2 inhibits glucocorticoid receptor transcriptional activity through a mechanism involving STAT5 (signal transducer and activator of transcription 5) but not AP-1.
Biola A; Lefebvre P; Perrin-Wolff M; Sturm M; Bertoglio J; Pallardy M
Mol Endocrinol; 2001 Jul; 15(7):1062-76. PubMed ID: 11435608
[TBL] [Abstract][Full Text] [Related]
28. Signal transducer and activator of transcription 5b: a new target of breast tumor kinase/protein tyrosine kinase 6.
Weaver AM; Silva CM
Breast Cancer Res; 2007; 9(6):R79. PubMed ID: 17997837
[TBL] [Abstract][Full Text] [Related]
29. Nuclear factor of activated T cells 1 (NFAT1)-induced permissive chromatin modification facilitates nuclear factor-κB (NF-κB)-mediated interleukin-9 (IL-9) transactivation.
Jash A; Sahoo A; Kim GC; Chae CS; Hwang JS; Kim JE; Im SH
J Biol Chem; 2012 May; 287(19):15445-57. PubMed ID: 22427656
[TBL] [Abstract][Full Text] [Related]
30. p300/CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response.
Pfitzner E; Jähne R; Wissler M; Stoecklin E; Groner B
Mol Endocrinol; 1998 Oct; 12(10):1582-93. PubMed ID: 9773981
[TBL] [Abstract][Full Text] [Related]
31. CD147 regulates melanoma metastasis via the NFAT1-MMP-9 pathway.
Liu N; Qi M; Li K; Zeng W; Li J; Yin M; Liu H; Chen X; Zhang J; Peng C
Pigment Cell Melanoma Res; 2020 Sep; 33(5):731-743. PubMed ID: 32339381
[TBL] [Abstract][Full Text] [Related]
32. A Common Docking Domain in Progesterone Receptor-B links DUSP6 and CK2 signaling to proliferative transcriptional programs in breast cancer cells.
Hagan CR; Knutson TP; Lange CA
Nucleic Acids Res; 2013 Oct; 41(19):8926-42. PubMed ID: 23921636
[TBL] [Abstract][Full Text] [Related]
33. Interaction between FGFR-2, STAT5, and progesterone receptors in breast cancer.
Cerliani JP; Guillardoy T; Giulianelli S; Vaque JP; Gutkind JS; Vanzulli SI; Martins R; Zeitlin E; Lamb CA; Lanari C
Cancer Res; 2011 May; 71(10):3720-31. PubMed ID: 21464042
[TBL] [Abstract][Full Text] [Related]
34. Loss of Nuclear Localized Parathyroid Hormone-Related Protein in Primary Breast Cancer Predicts Poor Clinical Outcome and Correlates with Suppressed Stat5 Signaling.
Tran TH; Utama FE; Sato T; Peck AR; Langenheim JF; Udhane SS; Sun Y; Liu C; Girondo MA; Kovatich AJ; Hooke JA; Shriver CD; Hu H; Palazzo JP; Bibbo M; Auer PW; Flister MJ; Hyslop T; Mitchell EP; Chervoneva I; Rui H
Clin Cancer Res; 2018 Dec; 24(24):6355-6366. PubMed ID: 30097435
[TBL] [Abstract][Full Text] [Related]
35. Intrinsic HER4/4ICD transcriptional activation domains are required for STAT5A activated gene expression.
Han W; Sfondouris ME; Semmes EC; Meyer AM; Jones FE
Gene; 2016 Oct; 592(1):221-226. PubMed ID: 27502417
[TBL] [Abstract][Full Text] [Related]
36. TIS21
Sundaramoorthy S; Devanand P; Ryu MS; Song KY; Noh DY; Lim IK
J Cancer Res Clin Oncol; 2018 Aug; 144(8):1445-1462. PubMed ID: 29808317
[TBL] [Abstract][Full Text] [Related]
37. Simultaneous, bidirectional inhibitory crosstalk between PPAR and STAT5b.
Shipley JM; Waxman DJ
Toxicol Appl Pharmacol; 2004 Sep; 199(3):275-84. PubMed ID: 15364543
[TBL] [Abstract][Full Text] [Related]
38. NFAT indicates nucleocytoplasmic damped oscillation via its feedback modulator.
Muramatsu M; Ito T; Shimoji H; Komiya M; Miyamura Y; Nishiyama K; Suzuki T; Minami T
Biochem Biophys Res Commun; 2021 Sep; 571():201-209. PubMed ID: 34332425
[TBL] [Abstract][Full Text] [Related]
39. Src-family kinases negatively regulate NFAT signaling in resting human T cells.
Baer A; Colon-Moran W; Xiang J; Stapleton JT; Bhattarai N
PLoS One; 2017; 12(10):e0187123. PubMed ID: 29073235
[TBL] [Abstract][Full Text] [Related]
40. SOCS3 as a tumor suppressor in breast cancer cells, and its regulation by PRL.
Barclay JL; Anderson ST; Waters MJ; Curlewis JD
Int J Cancer; 2009 Apr; 124(8):1756-66. PubMed ID: 19115200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
